JAAD Online
Comment on “Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up”

https://doi.org/10.1016/j.jaad.2018.10.078Get rights and content

References (5)

There are more references available in the full text version of this article.

Cited by (2)

  • Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology

    2020, Anais Brasileiros de Dermatologia
    Citation Excerpt :

    Isotretinoin is widely cited, with differences regarding efficacy, safety, time to remission, and relapses.209 In a retrospective study involving 82 patients, 16 (20%) used isotretinoin; eight (50%) improved, but the duration of the response was only three months.210 A multicenter, prospective study included 60 patients with QFD and different treatments; 15 (25%) were treated with isotretinoin for three months, with no difference in efficacy compared with the combination of rifampicin and clindamycin in the five-year follow-up.

Funding sources: None.

Conflicts of interest: None disclosed.

View full text